[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-364522-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-364522-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","transcriptome-analysis-of-ovarian-cancer-uncovers-association-between-tumor-related-inflammationimmunity-and-patient-outcome","Transcriptome analysis of ovarian cancer uncovers association between tumor-related inflammation/immunity and patient outcome","","Epithelial ovarian cancer is highly lethal and remains difficult to treat, with limited therapeutic benefit from existing PARPi and emerging immunotherapies. A comprehensive transcriptome analysis across multiple databases links inflammatory and immune-related gene programs to patient outcomes. Differential expression, pathway enrichment, co-expression network construction, and prognostic modeling identify distinct inflammatory patterns and immune microenvironment differences between risk groups. High-risk patients show increased M2 macrophage infiltration, altered anti-tumor immune activity, stemness-related features, poorer prognosis, and lower drug and checkpoint inhibitor responses.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/transcriptome-analysis-of-ovarian-cancer-uncovers-association-between-tumor-related-inflammationimmunity-and-patient-outcome/364522/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/transcriptome-analysis-of-ovarian-cancer-uncovers-association-between-tumor-related-inflammationimmunity-and-patient-outcome/364522.png","ImageObject",300,407,{"name":42,"@type":43},"Aria","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-25","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main focus of this study?","Question",{"text":63,"@type":64},"The study performs comprehensive transcriptome analysis to explore how tumor-related inflammation and immunity are associated with ovarian cancer immune microenvironment features and patient outcomes.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which analytical approaches were used in the study?",{"text":68,"@type":64},"Differential gene analysis, enrichment analysis, co-expression network construction, and prognostic model building were conducted using multiple R packages across several databases.",{"name":70,"@type":61,"acceptedAnswer":71},"What distinguishes the high-risk group in the results?",{"text":72,"@type":64},"The high-risk group shows higher M2-type macrophage infiltration, differences in anti-tumor immune response, higher tumor stemness score, potentially worse prognosis, and lower response rates to multiple chemotherapy drugs and immune checkpoint inhibitors.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},364522,1790773215,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":127,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},2336464648322,"https://ap-avatar.wpscdn.com/avatar/2200025388227c56fec?_k=1778556882303663488","TYPE Original Research PUBLISHED 06 February 2025 DOI 10.3389/fphar.2025.1500251  \nOPEN ACCESS  \nEDITED BY  \nJianbin Bi,  \nThe First Hospital of China Medical University, China  \nREVIEWED BY  \nYutao Wang,  \nChinese Academy of Medical Sciences and Peking Union Medical College, China Yu Tian,  \nBenedictine University, United States Anne Krogsdam,  \nInnsbruck Medical University, Austria  \n*CORRESPONDENCE  \nWenhao Wang,  \n [wwh199459@sxmu.edu.cn](wwh199459@sxmu.edu.cn)[ ](wwh199459@sxmu.edu.cn)Jingfang Wang,  \n [wangjingfang740401@163.com](wangjingfang740401@163.com)  \nRECEIVED 23 September 2024  \nACCEPTED 20 January 2025  \nPUBLISHED 06 February 2025  \nCITATION  \nWang J, Zhu W, Li X, Wu Y, Ma W, Wang Y, Zhao W, Wei F and Wang W (2025)  \nTranscriptome analysis of ovarian cancer uncovers association between tumor-related inﬂammation/immunity and patient outcome. Front. Pharmacol. 16:1500251 .  \ndoi: 10.3389/fphar.2025.1500251  \nCOPYRIGHT  \n© 2025 Wang, Zhu, Li, Wu, Ma, Wang, Zhao, Wei and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nTranscriptome analysis of ovarian cancer uncovers association between tumor-related inﬂammation/immunity and patient outcome  \nJingfang Wang 1*, Wenrui Zhu 1, Xia Li 1, Yuanyuan Wu 1, Wenhui Ma 1, Yangzhou Wang 2, Weihong Zhao 1, Fang Wei 1 and Wenhao Wang 1*  \n1Department of Obstetrics and Gynecology, Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China, 2Department of Stomatology, Changzhi Medical College, Changzhi, Shanxi, China  \nBackground: Epithelial ovarian cancer (EOC) is a cancer that affects the female reproductive system and is highly lethal. It poses signiﬁcant challenges in terms of treatment and often has a poor prognosis. In recent years, with the advent of PARPi, the treatment of ovarian cancer has entered a new stage of full-process management. Although more and more drugs have been approved, the therapeutic effect of PARPi is still very limited. With the rapid development of PD-1/PD-L1, CTLA-4, oncolytic viruses, cancer vaccines, adoptive cell therapy, etc., tumor immunotherapy has provided new opportunities for the treatment of ovarian cancer.  \nMethods: This study used comprehensive transcriptome analysis across multiple databases to gather gene transcripts and clinical features of normal ovarian samples and tissue samples from ovarian cancer. The aim was to explore the mechanisms underlying tumor immunotherapy resistance and to reveal the relationship between ovarian cancer’s immune microenvironment and genes linked to inﬂammation. Various R packages were used for differential gene analysis, enrichment analysis, co-expression network construction, and prognostic model building.  \nResults: It has been found that the prognosis of ovarian cancer patients is closely associated with sets of genes involved in inﬂammation. The immune inﬁltration microenvironment, clinicopathological features, and survival rates differed signiﬁcantly between two inﬂammatory gene expression patterns identiﬁed using cluster and immune microenvironment analyses. Further analysis revealed that the high-risk group had a higher abundance of M2-type macrophage inﬁltration, more active anti-tumor immune response, higher tumor stemness score, potentially worse prognosis, and lower response rates to multiple chemotherapy drugs and immune checkpoint inhibitors.  \nConclusion: These ﬁndings provide new perspectives and potential targets for immunotherapy and prognostic evaluation of ovarian cancer and offer new strategies and directions for clinical treatment and patient management. This  \nFrontiers ","cbCain2P8uAwKAq3","https://ap.wps.com/l/cbCain2P8uAwKAq3","pdf",8144085,"English","# Abstract\n# Background\n# Methods\n# Results\n# Conclusion\n# Keywords\n# 1 Introduction","[{\"question\":\"What is the main focus of this study?\",\"answer\":\"The study performs comprehensive transcriptome analysis to explore how tumor-related inflammation and immunity are associated with ovarian cancer immune microenvironment features and patient outcomes.\"},{\"question\":\"Which analytical approaches were used in the study?\",\"answer\":\"Differential gene analysis, enrichment analysis, co-expression network construction, and prognostic model building were conducted using multiple R packages across several databases.\"},{\"question\":\"What distinguishes the high-risk group in the results?\",\"answer\":\"The high-risk group shows higher M2-type macrophage infiltration, differences in anti-tumor immune response, higher tumor stemness score, potentially worse prognosis, and lower response rates to multiple chemotherapy drugs and immune checkpoint inhibitors.\"}]","Transcriptome analysis of ovarian cancer uncovers association between tumor-related inflammation/immunity and patient outcome | PDF",1790157935,48,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/107c40365b653e83c167ea2dc667b1b8.webp",983,1390,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/457bedbe7b1c3aa016e6fd38e71fc407.webp",982,1388,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a4495563ec446c44cf8bc169723f09e6.webp",981,1387,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fe330a82381cb463d439b8d7a2427551.webp",980,1385]